Suppr超能文献

C1q受体:调节吞噬细胞的特定功能。

C1q receptors: regulating specific functions of phagocytic cells.

作者信息

Tenner A J

机构信息

Department of Molecular Biology and Biochemistry, University of California, Irvine, USA.

出版信息

Immunobiology. 1998 Aug;199(2):250-64. doi: 10.1016/S0171-2985(98)80031-4.

Abstract

A C1q receptor that upregulates the phagocytic capacity of professional phagocytes, C1qRp, has been identified, and its primary structure determined by cDNA cloning and sequencing. Monoclonal antibodies that immunoprecipitate this 126,000 Mr polypeptide inhibit the enhancement of phagocytosis triggered not only by C1q but also by mannose binding lectin (MBL) and pulmonary surfactant protein A (SPA) providing critical evidence that this polypeptide is a functional receptor or component of the receptor that mediates this enhancement of phagocytosis. The amino acid sequence, deduced from the cloned cDNA coding for this receptor, indicates that this surface glycoprotein receptor is a novel type I membrane protein of 631 amino acid containing a region homologous to C-type lectin carbohydrate recognition domains, 5 EGF-like domains, a single transmembrane domain and a 47 amino acid intracellular domain. Expression of this receptor is limited to cells of myeloid origin, platelets and endothelial cells, consistent with a relatively selective function, and making it an attractive candidate for therapeutic modulation of function. A distinct C1q receptor that triggers superoxide in polymorphonuclear leukocytes has been functionally characterized and designated as C1qRO2-. Thus, the accumulated data that will be summarized here demonstrate that there are at least two C1q receptor/receptor complexes (C1qRp and C1qRO2-), each triggering distinct cellular responses, that multiple C1q receptors can be expressed on the same, as well as on different, cell types, and that at least one C1q receptor, C1qRp, is capable of responding to multiple ligands.

摘要

一种能上调专职吞噬细胞吞噬能力的C1q受体C1qRp已被鉴定出来,其一级结构通过cDNA克隆和测序得以确定。能免疫沉淀这条126,000 Mr多肽的单克隆抗体不仅抑制由C1q引发的吞噬作用增强,还抑制由甘露糖结合凝集素(MBL)和肺表面活性蛋白A(SPA)引发的吞噬作用增强,这提供了关键证据,表明该多肽是介导这种吞噬作用增强的功能性受体或受体的组成部分。从编码该受体的克隆cDNA推导出来的氨基酸序列表明,这种表面糖蛋白受体是一种新型的I型膜蛋白,由631个氨基酸组成,含有一个与C型凝集素碳水化合物识别结构域同源的区域、5个表皮生长因子样结构域、一个单一跨膜结构域和一个47个氨基酸的细胞内结构域。该受体的表达仅限于髓系来源的细胞、血小板和内皮细胞,这与相对选择性的功能一致,使其成为功能治疗性调节的有吸引力的候选者。一种能在多形核白细胞中引发超氧化物的独特C1q受体已在功能上得到表征,并被命名为C1qRO2-。因此,这里将总结的累积数据表明,至少存在两种C1q受体/受体复合物(C1qRp和C1qRO2-),每种复合物引发不同的细胞反应,多种C1q受体可在相同以及不同的细胞类型上表达,并且至少一种C1q受体C1qRp能够对多种配体作出反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验